Temat: "Nasopharyngeal carcinoma" - OpacWWW

Skocz do pozycji: 1.

Tytuł:: Efficacy of salvage surgery versus re-irradiation for isolated regional lymph node recurrence in patients with nasopharyngeal carcinoma.
Autorzy:: Chen Y; Department of Radiation Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, 350014, China.
Huang Y; Department of Radiation Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, 350014, China.
Chen X; Department of Otolaryngology, Fujian Medical University Union Hospital, Fuzhou, Fujian, China.
Chen Z; Department of Preventive Medicine, School of Public Health, Fujian Medical University, Fuzhou, Fujian, China.; Fuzhou Center for Disease Control and Prevention, Fuzhou, Fujian, China.
Peng X; Key Laboratory of Ministry of Education for Gastrointestinal Cancer, Fujian Medical University, Fuzhou, Fujian, China.
Lin S; Department of Radiation Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, 350014, China.; Fujian Key Laboratory of Translational Cancer Medicine, Fuzhou, Fujian, China.
Lin C; Department of Radiation Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, 350014, China. .
Zong J; Department of Radiation Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, 350014, China. .; Pokaż więcej
Źródło:: BMC cancer [BMC Cancer] 2024 Apr 16; Vol. 24 (1), pp. 483. Date of Electronic Publication: 2024 Apr 16.
Typ publikacji:: Journal Article
MeSH Terms:: Nasopharyngeal Neoplasms*/radiotherapy
Nasopharyngeal Neoplasms*/surgery
Re-Irradiation*
Humans ; Nasopharyngeal Carcinoma/radiotherapy ; Nasopharyngeal Carcinoma/pathology ; Retrospective Studies ; Neoplasm Staging ; Neoplasm Recurrence, Local/pathology ; Prognosis ; Lymph Nodes/pathology

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 2.

Tytuł:: Prognostic value of pre-treatment [ F] FDG PET/CT in recurrent nasopharyngeal carcinoma without distant metastasis.
Autorzy:: Dong Z; Department of Radiation Oncology, State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, 510060, Guangzhou, P. R. China.
Wang GY; Department of Radiation Oncology, State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, 510060, Guangzhou, P. R. China.
Dai DY; Department of Radiation Oncology, State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, 510060, Guangzhou, P. R. China.
Qin GJ; Department of Radiation Oncology, State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, 510060, Guangzhou, P. R. China.
Tang LL; Department of Radiation Oncology, State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, 510060, Guangzhou, P. R. China.
Xu C; Department of Radiation Oncology, State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, 510060, Guangzhou, P. R. China. .
Ma J; Department of Radiation Oncology, State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, 510060, Guangzhou, P. R. China. .; Pokaż więcej
Źródło:: BMC cancer [BMC Cancer] 2024 Apr 15; Vol. 24 (1), pp. 466. Date of Electronic Publication: 2024 Apr 15.
Typ publikacji:: Journal Article
MeSH Terms:: Positron Emission Tomography Computed Tomography*/methods
Nasopharyngeal Neoplasms*/diagnostic imaging
Nasopharyngeal Neoplasms*/therapy
Nasopharyngeal Neoplasms*/pathology
Humans ; Fluorodeoxyglucose F18 ; Nasopharyngeal Carcinoma/diagnostic imaging ; Nasopharyngeal Carcinoma/therapy ; Nasopharyngeal Carcinoma/pathology ; Prognosis ; Retrospective Studies ; Neoplasm Recurrence, Local/diagnostic imaging ; Neoplasm Recurrence, Local/pathology ; Positron-Emission Tomography/methods ; Radiopharmaceuticals ; Neoplasm Staging

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 3.

Tytuł:: Pretreatment multiparametric MRI radiomics-integrated clinical hematological biomarkers can predict early rapid metastasis in patients with nasopharyngeal carcinoma.
Autorzy:: Cao X; Shandong University Cancer Center, Shandong University, Jinan, Shandong, China.; Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, China.
Wang X; Shandong University Cancer Center, Shandong University, Jinan, Shandong, China.; Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, China.
Song J; Medical Imageology, Shandong Medical College, Jinan, China.
Su Y; Department of Radiation Oncology Physics and Technology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jiyan Road 440, Jinan, Shandong, 250117, People's Republic of China.
Wang L; Department of Radiation Oncology Physics and Technology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jiyan Road 440, Jinan, Shandong, 250117, People's Republic of China.
Yin Y; Shandong University Cancer Center, Shandong University, Jinan, Shandong, China. .; Department of Radiation Oncology Physics and Technology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jiyan Road 440, Jinan, Shandong, 250117, People's Republic of China. .; Pokaż więcej
Źródło:: BMC cancer [BMC Cancer] 2024 Apr 08; Vol. 24 (1), pp. 435. Date of Electronic Publication: 2024 Apr 08.
Typ publikacji:: Journal Article
MeSH Terms:: Multiparametric Magnetic Resonance Imaging*
Nasopharyngeal Neoplasms*/diagnostic imaging
Nasopharyngeal Neoplasms*/therapy
Humans ; Nasopharyngeal Carcinoma/diagnostic imaging ; Nasopharyngeal Carcinoma/therapy ; Radiomics ; Biomarkers ; Nomograms ; Retrospective Studies

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 4.

Tytuł:: Cytoplasmic poly(A)-binding protein 1 (PABPC1) is a prognostic biomarker to predict survival in nasopharyngeal carcinoma regardless of chemoradiotherapy.
Autorzy:: Ling F; Pathology Department of the First Affiliated Hospital, Southwest Medical University, Sichuan, People's Republic of China.
Xu S; Department of Otorhinolaryngology-Head and Neck Surgery, the Affiliated Hospital of Southwest Medical University, Sichuan, People's Republic of China.
Li X; Pathology Department of the First Affiliated Hospital, Southwest Medical University, Sichuan, People's Republic of China.
Sun X; Pathology Department of the First Affiliated Hospital, Southwest Medical University, Sichuan, People's Republic of China.
Long W; Pathology Department of the First Affiliated Hospital, Southwest Medical University, Sichuan, People's Republic of China. .; Pokaż więcej
Źródło:: BMC cancer [BMC Cancer] 2023 Feb 20; Vol. 23 (1), pp. 169. Date of Electronic Publication: 2023 Feb 20.
Typ publikacji:: Journal Article
MeSH Terms:: Nasopharyngeal Carcinoma*/diagnosis
Nasopharyngeal Carcinoma*/therapy
Nasopharyngeal Neoplasms*/diagnosis
Nasopharyngeal Neoplasms*/therapy
Poly(A)-Binding Protein I*/genetics
Humans ; Chemoradiotherapy ; Induction Chemotherapy ; Ki-67 Antigen ; Paclitaxel/therapeutic use ; Poly(A)-Binding Proteins ; Prognosis ; Tumor Suppressor Protein p53

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 5.

Tytuł:: The association of HBV infection and head and neck cancer: a systematic review and meta-analysis.
Autorzy:: Tan R; Hospital of Stomatology, Sun Yat-sen University, 56th Lingyuanxi Road, 510055, Guangzhou, Guangdong, China.; Guangdong Province Key Laboratory of Stomatology, No. 74, 2nd Zhongshan Road, 510080, Guangzhou, Guangdong, China.
Zhu X; Hospital of Stomatology, Sun Yat-sen University, 56th Lingyuanxi Road, 510055, Guangzhou, Guangdong, China.; Guangdong Province Key Laboratory of Stomatology, No. 74, 2nd Zhongshan Road, 510080, Guangzhou, Guangdong, China.
Sun Y; Hospital of Stomatology, Sun Yat-sen University, 56th Lingyuanxi Road, 510055, Guangzhou, Guangdong, China.; Guangdong Province Key Laboratory of Stomatology, No. 74, 2nd Zhongshan Road, 510080, Guangzhou, Guangdong, China.
Yang S; Hospital of Stomatology, Sun Yat-sen University, 56th Lingyuanxi Road, 510055, Guangzhou, Guangdong, China.; Guangdong Province Key Laboratory of Stomatology, No. 74, 2nd Zhongshan Road, 510080, Guangzhou, Guangdong, China.
Peng C; Hospital of Stomatology, Sun Yat-sen University, 56th Lingyuanxi Road, 510055, Guangzhou, Guangdong, China.; Guangdong Province Key Laboratory of Stomatology, No. 74, 2nd Zhongshan Road, 510080, Guangzhou, Guangdong, China.
Feng X; Hospital of Stomatology, Sun Yat-sen University, 56th Lingyuanxi Road, 510055, Guangzhou, Guangdong, China.; Guangdong Province Key Laboratory of Stomatology, No. 74, 2nd Zhongshan Road, 510080, Guangzhou, Guangdong, China.
Chen Z; Hospital of Stomatology, Sun Yat-sen University, 56th Lingyuanxi Road, 510055, Guangzhou, Guangdong, China.; Guangdong Province Key Laboratory of Stomatology, No. 74, 2nd Zhongshan Road, 510080, Guangzhou, Guangdong, China.
Yimamu Y; The First People's Hospital of Kashi Area, Xinjiang Uygur Autonomous Region, No.120, Yingbin Avenue, Kashi, People's Republic of China.
Liao G; Hospital of Stomatology, Sun Yat-sen University, 56th Lingyuanxi Road, 510055, Guangzhou, Guangdong, China. .; Guangdong Province Key Laboratory of Stomatology, No. 74, 2nd Zhongshan Road, 510080, Guangzhou, Guangdong, China. .
Yang L; Hospital of Stomatology, Sun Yat-sen University, 56th Lingyuanxi Road, 510055, Guangzhou, Guangdong, China. .; Guangdong Province Key Laboratory of Stomatology, No. 74, 2nd Zhongshan Road, 510080, Guangzhou, Guangdong, China. .; Pokaż więcej
Źródło:: BMC cancer [BMC Cancer] 2024 Feb 16; Vol. 24 (1), pp. 225. Date of Electronic Publication: 2024 Feb 16.
Typ publikacji:: Meta-Analysis; Systematic Review; Journal Article
MeSH Terms:: Hepatitis B*/complications
Hepatitis B*/epidemiology
Head and Neck Neoplasms*/etiology
Head and Neck Neoplasms*/complications
Nasopharyngeal Neoplasms*/complications
Mouth Neoplasms*
Humans ; Hepatitis B virus ; Cohort Studies ; Nasopharyngeal Carcinoma/complications

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 6.

Tytuł:: Neoadjuvant chemotherapy followed by concurrent chemoradiotherapy with or without nimotuzumab in the treatment of locally advanced nasopharyngeal carcinoma: a retrospective study.
Autorzy:: Yang Z; Department of Oncology, People's Hospital of Xiangxi Tujia and Miao Autonomous Prefecture, First Affiliated Hospital of Jishou University, Jishou, 416000, Hunan, China.
Zuo Q; Department of Oncology, People's Hospital of Xiangxi Tujia and Miao Autonomous Prefecture, First Affiliated Hospital of Jishou University, Jishou, 416000, Hunan, China.
Liu R; Department of Oncology, People's Hospital of Xiangxi Tujia and Miao Autonomous Prefecture, First Affiliated Hospital of Jishou University, Jishou, 416000, Hunan, China.
Wu H; Department of Oncology, People's Hospital of Xiangxi Tujia and Miao Autonomous Prefecture, First Affiliated Hospital of Jishou University, Jishou, 416000, Hunan, China.
Xiong L; Department of Oncology, People's Hospital of Xiangxi Tujia and Miao Autonomous Prefecture, First Affiliated Hospital of Jishou University, Jishou, 416000, Hunan, China.
Jia J; Department of Otolaryngology, People's Hospital of Xiangxi Tujia and Miao Autonomous Prefecture, First Affiliated Hospital of Jishou University, Jishou, 416000, Hunan, China. .
Xiang Z; Department of Oncology, People's Hospital of Xiangxi Tujia and Miao Autonomous Prefecture, First Affiliated Hospital of Jishou University, Jishou, 416000, Hunan, China. .; Pokaż więcej
Źródło:: BMC cancer [BMC Cancer] 2023 Nov 24; Vol. 23 (1), pp. 1140. Date of Electronic Publication: 2023 Nov 24.
Typ publikacji:: Journal Article
MeSH Terms:: Nasopharyngeal Neoplasms*/drug therapy
Nasopharyngeal Neoplasms*/pathology
Leukopenia*/chemically induced
Humans ; Nasopharyngeal Carcinoma/drug therapy ; Nasopharyngeal Carcinoma/pathology ; Retrospective Studies ; Neoadjuvant Therapy/adverse effects ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Neoplasm Recurrence, Local/drug therapy ; Chemoradiotherapy/adverse effects ; Cisplatin/adverse effects

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 7.

Tytuł:: Cyclin B2 impairs the p53 signaling in nasopharyngeal carcinoma.
Autorzy:: Liu Q; Department of Otolaryngology, Qingdao Municipal Hospital, NO. 1, Shibei District, Jiaozhou Road, 266011, Qingdao, Shandong, P.R. China.
Yuan Y; Department of Otolaryngology, Qingdao Municipal Hospital, NO. 1, Shibei District, Jiaozhou Road, 266011, Qingdao, Shandong, P.R. China.
Shang X; Department of Otolaryngology, Qingdao Municipal Hospital, NO. 1, Shibei District, Jiaozhou Road, 266011, Qingdao, Shandong, P.R. China.
Xin L; Department of Otolaryngology, Qingdao Municipal Hospital, NO. 1, Shibei District, Jiaozhou Road, 266011, Qingdao, Shandong, P.R. China. .; Pokaż więcej
Źródło:: BMC cancer [BMC Cancer] 2024 Jan 02; Vol. 24 (1), pp. 25. Date of Electronic Publication: 2024 Jan 02.
Typ publikacji:: Journal Article
MeSH Terms:: Cyclin B2*/genetics
Cyclin B2*/metabolism
Nasopharyngeal Carcinoma*/genetics
Nasopharyngeal Carcinoma*/pathology
Nasopharyngeal Neoplasms*/genetics
Nasopharyngeal Neoplasms*/pathology
Tumor Suppressor Protein p53*/genetics
Tumor Suppressor Protein p53*/metabolism
Humans ; Cell Line, Tumor ; Cell Movement/genetics ; Cell Proliferation/genetics ; Epithelial-Mesenchymal Transition/genetics ; Gene Expression Regulation, Neoplastic ; Jumonji Domain-Containing Histone Demethylases/metabolism ; Signal Transduction/genetics

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 8.

Tytuł:: Preliminary evidence for endoscopic surgery combined with postoperative anti-PD-1 immunotherapy in advanced recurrent nasopharyngeal carcinoma.
Autorzy:: Xu H; ENT institute and Department of Otorhinolaryngology, Eye & ENT Hospital, Fudan University, Shanghai, 200031, China.
Li W; ENT institute and Department of Otorhinolaryngology, Eye & ENT Hospital, Fudan University, Shanghai, 200031, China.
Zhang H; ENT institute and Department of Otorhinolaryngology, Eye & ENT Hospital, Fudan University, Shanghai, 200031, China.
Wang H; ENT institute and Department of Otorhinolaryngology, Eye & ENT Hospital, Fudan University, Shanghai, 200031, China.
Hu L; ENT institute and Department of Otorhinolaryngology, Eye & ENT Hospital, Fudan University, Shanghai, 200031, China.
Gu Y; ENT institute and Department of Otorhinolaryngology, Eye & ENT Hospital, Fudan University, Shanghai, 200031, China. .
Wang D; ENT institute and Department of Otorhinolaryngology, Eye & ENT Hospital, Fudan University, Shanghai, 200031, China. .; Pokaż więcej
Źródło:: BMC cancer [BMC Cancer] 2023 Dec 21; Vol. 23 (1), pp. 1259. Date of Electronic Publication: 2023 Dec 21.
Typ publikacji:: Journal Article
MeSH Terms:: Nasopharyngeal Neoplasms*/drug therapy
Nasopharyngeal Neoplasms*/surgery
Humans ; Nasopharyngeal Carcinoma/drug therapy ; Retrospective Studies ; Progression-Free Survival ; Immunotherapy/adverse effects

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 9.

Tytuł:: Nomogram incorporating Epstein-Barr virus DNA and a novel immune-nutritional marker for survival prediction in nasopharyngeal carcinoma.
Autorzy:: Wu S; Department of Otolaryngology-Head and Neck Surgery, Nanfang Hospital, Southern Medical University, Jingxi Street, Baiyun District, Guangzhou, 510515, P.R. China.
Yuan X; Department of Otolaryngology-Head and Neck Surgery, Nanfang Hospital, Southern Medical University, Jingxi Street, Baiyun District, Guangzhou, 510515, P.R. China.
Huang H; Department of Otolaryngology-Head and Neck Surgery, Nanfang Hospital, Southern Medical University, Jingxi Street, Baiyun District, Guangzhou, 510515, P.R. China.
Li Y; Department of Otolaryngology-Head and Neck Surgery, Nanfang Hospital, Southern Medical University, Jingxi Street, Baiyun District, Guangzhou, 510515, P.R. China.
Cui L; Department of Otolaryngology-Head and Neck Surgery, Nanfang Hospital, Southern Medical University, Jingxi Street, Baiyun District, Guangzhou, 510515, P.R. China.
Lin D; Department of Otolaryngology-Head and Neck Surgery, Nanfang Hospital, Southern Medical University, Jingxi Street, Baiyun District, Guangzhou, 510515, P.R. China.
Lu W; Department of Otolaryngology-Head and Neck Surgery, Nanfang Hospital, Southern Medical University, Jingxi Street, Baiyun District, Guangzhou, 510515, P.R. China.
Feng H; Department of Otolaryngology-Head and Neck Surgery, Nanfang Hospital, Southern Medical University, Jingxi Street, Baiyun District, Guangzhou, 510515, P.R. China.
Chen Z; Department of Otolaryngology-Head and Neck Surgery, Nanfang Hospital, Southern Medical University, Jingxi Street, Baiyun District, Guangzhou, 510515, P.R. China.
Liu X; Department of Otolaryngology-Head and Neck Surgery, Nanfang Hospital, Southern Medical University, Jingxi Street, Baiyun District, Guangzhou, 510515, P.R. China. .
Tan J; Department of Otolaryngology-Head and Neck Surgery, Nanfang Hospital, Southern Medical University, Jingxi Street, Baiyun District, Guangzhou, 510515, P.R. China. .
Wang F; Department of Otolaryngology-Head and Neck Surgery, Nanfang Hospital, Southern Medical University, Jingxi Street, Baiyun District, Guangzhou, 510515, P.R. China. .; Pokaż więcej
Źródło:: BMC cancer [BMC Cancer] 2023 Dec 09; Vol. 23 (1), pp. 1217. Date of Electronic Publication: 2023 Dec 09.
Typ publikacji:: Journal Article
MeSH Terms:: Epstein-Barr Virus Infections*
Nasopharyngeal Neoplasms*/pathology
Humans ; Biomarkers ; DNA, Viral/genetics ; Herpesvirus 4, Human/genetics ; Nasopharyngeal Carcinoma/pathology ; Neoplasm Staging ; Nomograms ; Prognosis ; Retrospective Studies

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 10.

Tytuł:: Efficacy and safety of PD-1 inhibitors in recurrent or metastatic nasopharyngeal carcinoma patients after failure of platinum-containing regimens: a systematic review and meta-analysis.
Autorzy:: Luo J; Department of Oncology, The First Affiliated Hospital of Guangdong Pharmaceutical University, Guangdong Pharmaceutical University, Guangzhou, 510062, China.
Xiao W; Department of Oncology, The First Affiliated Hospital of Guangdong Pharmaceutical University, Guangdong Pharmaceutical University, Guangzhou, 510062, China.
Hua F; Department of Oncology, The First Affiliated Hospital of Guangdong Pharmaceutical University, Guangdong Pharmaceutical University, Guangzhou, 510062, China.
Cao Y; Department of Oncology, The First Affiliated Hospital of Guangdong Pharmaceutical University, Guangdong Pharmaceutical University, Guangzhou, 510062, China.
Wang D; Affiliated Dongguan People's Hospital, Southern Medical University (Dongguan People's Hospital), Dongguan, 523058, China. .
Wang X; Department of Oncology, The First Affiliated Hospital of Guangdong Pharmaceutical University, Guangdong Pharmaceutical University, Guangzhou, 510062, China. .; Pokaż więcej
Źródło:: BMC cancer [BMC Cancer] 2023 Nov 30; Vol. 23 (1), pp. 1172. Date of Electronic Publication: 2023 Nov 30.
Typ publikacji:: Meta-Analysis; Systematic Review; Journal Article
MeSH Terms:: Immune Checkpoint Inhibitors*/adverse effects
Nasopharyngeal Neoplasms*/drug therapy
Humans ; Nasopharyngeal Carcinoma/drug therapy ; Platinum/therapeutic use ; B7-H1 Antigen ; Neoplasm Recurrence, Local/drug therapy ; Neoplasm Recurrence, Local/pathology

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 11.

Tytuł:: Impact of sex on treatment-related adverse effects and prognosis in nasopharyngeal carcinoma.
Autorzy:: Cui L; Department of Otolaryngology-Head and Neck Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, Guangdong, PR China.
Chen Z; Department of Otolaryngology-Head and Neck Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, Guangdong, PR China.
Zeng F; Department of Otolaryngology-Head and Neck Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, Guangdong, PR China.
Jiang X; Department of Otolaryngology-Head and Neck Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, Guangdong, PR China.
Han X; Department of Otolaryngology-Head and Neck Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, Guangdong, PR China.
Yuan X; Department of Otolaryngology-Head and Neck Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, Guangdong, PR China.
Wu S; Department of Otolaryngology-Head and Neck Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, Guangdong, PR China.
Feng H; Department of Otolaryngology-Head and Neck Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, Guangdong, PR China.
Lin D; Department of Otolaryngology-Head and Neck Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, Guangdong, PR China.
Lu W; Department of Otolaryngology-Head and Neck Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, Guangdong, PR China.
Liu X; Department of Otolaryngology-Head and Neck Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, Guangdong, PR China. .
Peng X; Department of Otolaryngology-Head and Neck Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, Guangdong, PR China. .
Yu B; Department of Otolaryngology-Head and Neck Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, Guangdong, PR China. .; Pokaż więcej
Źródło:: BMC cancer [BMC Cancer] 2023 Nov 25; Vol. 23 (1), pp. 1146. Date of Electronic Publication: 2023 Nov 25.
Typ publikacji:: Journal Article
MeSH Terms:: Nasopharyngeal Neoplasms*/pathology
Carcinoma*/pathology
Dermatitis*/pathology
Radiotherapy, Intensity-Modulated*
Male ; Humans ; Female ; Nasopharyngeal Carcinoma/pathology ; Retrospective Studies ; Prognosis ; Neoplasm Staging

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 12.

Tytuł:: Involved site radiation therapy in stage I-III nasopharyngeal carcinoma with limited lymph node burden (ISRT-NPC) or elective region irradiation: a study protocol for a multicenter non-inferiority randomized controlled phase III clinical trial.
Autorzy:: Liu Y; Department of Radiation Oncology, National Clinical Research Center for Cancer/Cancer Hospital, National Cancer Center, Chinese Academy of Medical Sciences and Peking Union Medical College, 17 Panjiayuan Nanli, Chaoyang District, Beijing, 100021, China.
Han Y; Department of Radiation Oncology, Hubei Cancer Hospital, Wuhan, 430079, Hubei Province, China.
Liu F; Department of Radiation Oncology, Hubei Cancer Hospital, Wuhan, 430079, Hubei Province, China.
Hu D; Department of Radiation Oncology, Hunan Cancer Hospital, Changsha, 410013, Hunan Province, China.
Chen Z; Department of Radiation Oncology, Guizhou Cancer Hospital, Guiyang, 550000, Guizhou Province, China.
Wang P; Department of Radiation Oncology, Jiangxi Cancer Hospital, Nanchang, 330029, Jiangxi Province, China.
Li J; Department of Radiation Oncology, Tianjin Medical University Cancer Institute & Hospital, Tianjin, 300060, China.
Qin J; Department of Radiation Oncology, Yunnan Cancer Hospital, Kunming, 650100, Yunnan Province, China.
Jin F; Department of Radiation Oncology, Cancer hospital Chinese academy of medical science, Shenzhen center, Shenzhen, 518127, Guangzhou Province, China.
Li Y; Department of Radiation Oncology, National Clinical Research Center for Cancer/Cancer Hospital, National Cancer Center, Chinese Academy of Medical Sciences and Peking Union Medical College, 17 Panjiayuan Nanli, Chaoyang District, Beijing, 100021, China.
Wang J; Department of Radiation Oncology, National Clinical Research Center for Cancer/Cancer Hospital, National Cancer Center, Chinese Academy of Medical Sciences and Peking Union Medical College, 17 Panjiayuan Nanli, Chaoyang District, Beijing, 100021, China. .
Yi J; Department of Radiation Oncology, National Clinical Research Center for Cancer/Cancer Hospital, National Cancer Center, Chinese Academy of Medical Sciences and Peking Union Medical College, 17 Panjiayuan Nanli, Chaoyang District, Beijing, 100021, China. .; Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Hebei Cancer Hospital, Chinese Academy of Medical Sciences (CAMS), Tongxi Road, Guangyang District, Langfang, 065001, Hebei Province, China. .; Pokaż więcej
Źródło:: BMC cancer [BMC Cancer] 2023 Aug 03; Vol. 23 (1), pp. 724. Date of Electronic Publication: 2023 Aug 03.
Typ publikacji:: Clinical Trial Protocol; Journal Article
MeSH Terms:: Quality of Life*
Nasopharyngeal Neoplasms*/pathology
Humans ; Nasopharyngeal Carcinoma/radiotherapy ; Nasopharyngeal Carcinoma/pathology ; Prospective Studies ; Lymphatic Metastasis/radiotherapy ; Lymphatic Metastasis/pathology ; Lymph Nodes/pathology ; Randomized Controlled Trials as Topic ; Multicenter Studies as Topic ; Clinical Trials, Phase III as Topic

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 13.

Tytuł:: Changing patterns of nasopharyngeal carcinoma incidence in Hong Kong: a 30-year analysis and future projections.
Autorzy:: Wang X; The Key Laboratory of Biomedical Information Engineering of Ministry of Education, School of Life Science and Technology, Xi'an Jiaotong University, No.28, Xianning West Road, Xi'an, Shaanxi, 710049, China.
Sun H; Third Department of Medical Oncology, Shaanxi Provincial Cancer Hospital Affiliated to Medical College of Xi'an Jiaotong University, Xi'an, Shaanxi, China.
Li L; Department of Clinical Medicine, Second Clinical School of Medicine, Shaanxi, University of Chinese Medicine, Xianyang, Shaanxi, China.
Gan Z; The Key Laboratory of Biomedical Information Engineering of Ministry of Education, School of Life Science and Technology, Xi'an Jiaotong University, No.28, Xianning West Road, Xi'an, Shaanxi, 710049, China.
Wu X; The Key Laboratory of Biomedical Information Engineering of Ministry of Education, School of Life Science and Technology, Xi'an Jiaotong University, No.28, Xianning West Road, Xi'an, Shaanxi, 710049, China.
Du J; The Key Laboratory of Biomedical Information Engineering of Ministry of Education, School of Life Science and Technology, Xi'an Jiaotong University, No.28, Xianning West Road, Xi'an, Shaanxi, 710049, China. .; Pokaż więcej
Źródło:: BMC cancer [BMC Cancer] 2023 Aug 16; Vol. 23 (1), pp. 761. Date of Electronic Publication: 2023 Aug 16.
Typ publikacji:: Journal Article
MeSH Terms:: Aging*
Nasopharyngeal Neoplasms*/epidemiology
Female ; Male ; Humans ; Hong Kong/epidemiology ; Incidence ; Nasopharyngeal Carcinoma/epidemiology

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 14.

Tytuł:: Percent change in apparent diffusion coefficient and plasma EBV DNA after induction chemotherapy identifies distinct prognostic response phenotypes in advanced nasopharyngeal carcinoma.
Autorzy:: Liu LT; State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine; Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer Center, Guangzhou, 510060, China.; Department of Nasopharyngeal Carcinoma, Sun Yat-sen University Cancer Center, 651 Dongfeng Road East, Guangzhou, 510060, China.
Guo SS; State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine; Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer Center, Guangzhou, 510060, China.; Department of Nasopharyngeal Carcinoma, Sun Yat-sen University Cancer Center, 651 Dongfeng Road East, Guangzhou, 510060, China.
Li H; State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine; Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer Center, Guangzhou, 510060, China.; Imaging Diagnosis and Interventional Center, Sun Yat-sen University Cancer Center, Guangzhou, 510060, China.
Lin C; State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine; Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer Center, Guangzhou, 510060, China.; Department of Nasopharyngeal Carcinoma, Sun Yat-sen University Cancer Center, 651 Dongfeng Road East, Guangzhou, 510060, China.
Sun R; State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine; Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer Center, Guangzhou, 510060, China.; Department of Nasopharyngeal Carcinoma, Sun Yat-sen University Cancer Center, 651 Dongfeng Road East, Guangzhou, 510060, China.
Chen QY; State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine; Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer Center, Guangzhou, 510060, China.; Department of Nasopharyngeal Carcinoma, Sun Yat-sen University Cancer Center, 651 Dongfeng Road East, Guangzhou, 510060, China.
Liang YJ; State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine; Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer Center, Guangzhou, 510060, China.; Department of Nasopharyngeal Carcinoma, Sun Yat-sen University Cancer Center, 651 Dongfeng Road East, Guangzhou, 510060, China.
Tang QN; State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine; Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer Center, Guangzhou, 510060, China.; Department of Nasopharyngeal Carcinoma, Sun Yat-sen University Cancer Center, 651 Dongfeng Road East, Guangzhou, 510060, China.
Sun XS; State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine; Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer Center, Guangzhou, 510060, China.; Department of Nasopharyngeal Carcinoma, Sun Yat-sen University Cancer Center, 651 Dongfeng Road East, Guangzhou, 510060, China.
Tang LQ; State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine; Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer Center, Guangzhou, 510060, China.; Department of Nasopharyngeal Carcinoma, Sun Yat-sen University Cancer Center, 651 Dongfeng Road East, Guangzhou, 510060, China.
Xie CM; State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine; Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer Center, Guangzhou, 510060, China.; Imaging Diagnosis and Interventional Center, Sun Yat-sen University Cancer Center, Guangzhou, 510060, China.
Mai HQ; State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine; Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer Center, Guangzhou, 510060, China. .; Department of Nasopharyngeal Carcinoma, Sun Yat-sen University Cancer Center, 651 Dongfeng Road East, Guangzhou, 510060, China. .; Pokaż więcej
Źródło:: BMC cancer [BMC Cancer] 2021 Dec 09; Vol. 21 (1), pp. 1320. Date of Electronic Publication: 2021 Dec 09.
Typ publikacji:: Journal Article
MeSH Terms:: Induction Chemotherapy*
Nasopharyngeal Carcinoma*/diagnostic imaging
Nasopharyngeal Carcinoma*/drug therapy
Nasopharyngeal Carcinoma*/epidemiology
Nasopharyngeal Carcinoma*/pathology
DNA, Viral/*blood
Herpesvirus 4, Human/*genetics
Adolescent ; Adult ; Aged ; Diffusion Magnetic Resonance Imaging ; Disease Progression ; Female ; Humans ; Male ; Middle Aged ; Prognosis ; Young Adult

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 15.

Tytuł:: Optimizing the treatment mode for de novo metastatic nasopharyngeal carcinoma with bone-only metastasis.
Autorzy:: Lin C; Department of Radiation Oncology, Fujian Medical University Cancer Hospital, Fujian Cancer Hospital, No. 420 Fuma Road, Fuzhou, 350014, China. .
Lin S; Department of Medical Oncology, Fuqing City Hospital of Fujian, Fuqing, Fuzhou, 350300, China.
Zhu L; Department of Radiation Oncology, Fuzhou Pulmonary Hospital of Fujian, Fuzhou, 350008, China.
Lin S; Department of Radiation Oncology, Fujian Medical University Cancer Hospital, Fujian Cancer Hospital, No. 420 Fuma Road, Fuzhou, 350014, China.
Pan J; Department of Radiation Oncology, Fujian Medical University Cancer Hospital, Fujian Cancer Hospital, No. 420 Fuma Road, Fuzhou, 350014, China.
Xu Y; Department of Radiation Oncology, Fujian Medical University Cancer Hospital, Fujian Cancer Hospital, No. 420 Fuma Road, Fuzhou, 350014, China. .; Pokaż więcej
Źródło:: BMC cancer [BMC Cancer] 2022 Jan 04; Vol. 22 (1), pp. 35. Date of Electronic Publication: 2022 Jan 04.
Typ publikacji:: Journal Article
MeSH Terms:: Bone Neoplasms/*secondary
Chemoradiotherapy/*mortality
Nasopharyngeal Carcinoma/*mortality
Nasopharyngeal Carcinoma/*therapy
Nasopharyngeal Neoplasms/*mortality
Nasopharyngeal Neoplasms/*therapy
Chemoradiotherapy/methods ; Female ; Humans ; Kaplan-Meier Estimate ; Male ; Middle Aged ; Multivariate Analysis ; Nasopharyngeal Carcinoma/pathology ; Nasopharyngeal Neoplasms/pathology ; Neoplasm Metastasis ; Palliative Care/methods ; Progression-Free Survival ; Proportional Hazards Models ; Retrospective Studies ; Survival Rate ; Treatment Outcome

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 16.

Tytuł:: Comparison of radiotherapy combined with nimotuzumab vs. chemoradiotherapy for locally recurrent nasopharyngeal carcinoma.
Autorzy:: Zong JF; Department of Radiation Oncology, Fujian Medical University Cancer Hospital, Fujian Cancer Hospital, No. 420 Fuma Road, Fuzhou, 350014, Fujian, China.
Liang QD; Department of Radiation Oncology, Fujian Medical University Cancer Hospital, Fujian Cancer Hospital, No. 420 Fuma Road, Fuzhou, 350014, Fujian, China.
Lu QJ; Department of Radiation Oncology, Fujian Medical University Cancer Hospital, Fujian Cancer Hospital, No. 420 Fuma Road, Fuzhou, 350014, Fujian, China.
Liu YH; Department of Radiation Oncology, Fujian Medical University Cancer Hospital, Fujian Cancer Hospital, No. 420 Fuma Road, Fuzhou, 350014, Fujian, China.
Xu HC; Department of Radiation Oncology, Fujian Medical University Cancer Hospital, Fujian Cancer Hospital, No. 420 Fuma Road, Fuzhou, 350014, Fujian, China.
Chen BJ; Department of Radiation Oncology, Fujian Medical University Cancer Hospital, Fujian Cancer Hospital, No. 420 Fuma Road, Fuzhou, 350014, Fujian, China.
Guo QJ; Department of Radiation Oncology, Fujian Medical University Cancer Hospital, Fujian Cancer Hospital, No. 420 Fuma Road, Fuzhou, 350014, Fujian, China.; Fujian Key Laboratory of Translational Cancer Medicine, Fuzhou, Fujian, China.; Key Laboratory of Systems Biomedicine (Ministry of Education), Shanghai Center for Systems Biomedicine, Shanghai Jiao Tong University, Shanghai, China.
Xu Y; Department of Radiation Oncology, Fujian Medical University Cancer Hospital, Fujian Cancer Hospital, No. 420 Fuma Road, Fuzhou, 350014, Fujian, China.
Hu CR; Department of Radiation Oncology, Fujian Medical University Cancer Hospital, Fujian Cancer Hospital, No. 420 Fuma Road, Fuzhou, 350014, Fujian, China.
Pan JJ; Department of Radiation Oncology, Fujian Medical University Cancer Hospital, Fujian Cancer Hospital, No. 420 Fuma Road, Fuzhou, 350014, Fujian, China.; Fujian Key Laboratory of Translational Cancer Medicine, Fuzhou, Fujian, China.
Lin SJ; Department of Radiation Oncology, Fujian Medical University Cancer Hospital, Fujian Cancer Hospital, No. 420 Fuma Road, Fuzhou, 350014, Fujian, China. .; Fujian Key Laboratory of Translational Cancer Medicine, Fuzhou, Fujian, China. .; Pokaż więcej
Źródło:: BMC cancer [BMC Cancer] 2021 Nov 25; Vol. 21 (1), pp. 1274. Date of Electronic Publication: 2021 Nov 25.
Typ publikacji:: Comparative Study; Journal Article
MeSH Terms:: Chemoradiotherapy*/adverse effects
Chemoradiotherapy*/mortality
Antibodies, Monoclonal, Humanized/*therapeutic use
Nasopharyngeal Carcinoma/*therapy
Nasopharyngeal Neoplasms/*therapy
Neoplasm Recurrence, Local/*therapy
Radiation-Sensitizing Agents/*therapeutic use
Antineoplastic Agents, Immunological/therapeutic use ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Female ; Humans ; Induction Chemotherapy/methods ; Male ; Middle Aged ; Mucositis/etiology ; Nasopharyngeal Carcinoma/mortality ; Nasopharyngeal Neoplasms/mortality ; Neoplasm Recurrence, Local/mortality ; Radiation Injuries/pathology ; Radiotherapy, Intensity-Modulated/adverse effects ; Retrospective Studies ; Survival Rate ; Xerostomia/etiology

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 17.

Tytuł:: Exosomal ERp44 derived from ER-stressed cells strengthens cisplatin resistance of nasopharyngeal carcinoma.
Autorzy:: Xia T; Department of Otorhinolaryngology Head and Neck surgery, Affiliated Hospital of Nantong University, Nantong, Jiangsu Province, China.; Institute of Otorhinolaryngology Head and Neck Surgery, Affiliated Hospital of Nantong University, Nantong, Jiangsu Province, China.; Medical College of Nantong University, Nantong, Jiangsu Province, China.
Tian H; Department of Otorhinolaryngology Head and Neck surgery, Affiliated Hospital of Nantong University, Nantong, Jiangsu Province, China.; Institute of Otorhinolaryngology Head and Neck Surgery, Affiliated Hospital of Nantong University, Nantong, Jiangsu Province, China.; Medical College of Nantong University, Nantong, Jiangsu Province, China.
Zhang K; Department of Otorhinolaryngology Head and Neck surgery, Affiliated Hospital of Nantong University, Nantong, Jiangsu Province, China.; Institute of Otorhinolaryngology Head and Neck Surgery, Affiliated Hospital of Nantong University, Nantong, Jiangsu Province, China.; Medical College of Nantong University, Nantong, Jiangsu Province, China.
Zhang S; Department of Otorhinolaryngology Head and Neck surgery, Affiliated Hospital of Nantong University, Nantong, Jiangsu Province, China.; Institute of Otorhinolaryngology Head and Neck Surgery, Affiliated Hospital of Nantong University, Nantong, Jiangsu Province, China.; Medical College of Nantong University, Nantong, Jiangsu Province, China.
Chen W; Department of Otorhinolaryngology Head and Neck surgery, Affiliated Hospital of Nantong University, Nantong, Jiangsu Province, China.; Institute of Otorhinolaryngology Head and Neck Surgery, Affiliated Hospital of Nantong University, Nantong, Jiangsu Province, China.; Medical College of Nantong University, Nantong, Jiangsu Province, China.
Shi S; Department of Otorhinolaryngology Head and Neck surgery, Affiliated Hospital of Nantong University, Nantong, Jiangsu Province, China. .; Institute of Otorhinolaryngology Head and Neck Surgery, Affiliated Hospital of Nantong University, Nantong, Jiangsu Province, China. .; Medical College of Nantong University, Nantong, Jiangsu Province, China. .
You Y; Department of Otorhinolaryngology Head and Neck surgery, Affiliated Hospital of Nantong University, Nantong, Jiangsu Province, China. youyiwen_.; Institute of Otorhinolaryngology Head and Neck Surgery, Affiliated Hospital of Nantong University, Nantong, Jiangsu Province, China. youyiwen_.; Medical College of Nantong University, Nantong, Jiangsu Province, China. youyiwen_.; Pokaż więcej
Źródło:: BMC cancer [BMC Cancer] 2021 Sep 08; Vol. 21 (1), pp. 1003. Date of Electronic Publication: 2021 Sep 08.
Typ publikacji:: Journal Article
MeSH Terms:: Drug Resistance, Neoplasm*
Endoplasmic Reticulum Stress*
Unfolded Protein Response*
Cisplatin/*pharmacology
Exosomes/*metabolism
Membrane Proteins/*metabolism
Molecular Chaperones/*metabolism
Nasopharyngeal Carcinoma/*drug therapy
Animals ; Antineoplastic Agents/pharmacology ; Apoptosis ; Cell Proliferation ; Endoplasmic Reticulum Chaperone BiP ; Exosomes/genetics ; Humans ; Membrane Proteins/genetics ; Mice ; Mice, Inbred BALB C ; Mice, Nude ; Molecular Chaperones/genetics ; Nasopharyngeal Carcinoma/metabolism ; Nasopharyngeal Carcinoma/pathology ; Nasopharyngeal Neoplasms/drug therapy ; Nasopharyngeal Neoplasms/metabolism ; Nasopharyngeal Neoplasms/pathology ; Signal Transduction ; Tumor Cells, Cultured ; Xenograft Model Antitumor Assays

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 18.

Tytuł:: Influence of Epstein-Barr virus and human papillomavirus infection on macrophage migration inhibitory factor and macrophage polarization in nasopharyngeal carcinoma.
Autorzy:: Feng G; Department of Environmental and Molecular Medicine, Mie University Graduate School of Medicine, Tsu, 514-8507, Japan.; Department of Otorhinolaryngology-Head and Neck Surgery, Mie University Graduate School of Medicine, Tsu, 514-8507, Japan.
Xu Y; Department of Environmental and Molecular Medicine, Mie University Graduate School of Medicine, Tsu, 514-8507, Japan.; Department of Otorhinolaryngology-Head and Neck Surgery, Mie University Graduate School of Medicine, Tsu, 514-8507, Japan.; Department of Otorhinolaryngology-Head and Neck Surgery, First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, China.
Ma N; Graduate School of Health Science, Suzuka University of Medical Science, Suzuka, 510-0226, Japan.
Midorikawa K; Department of Environmental and Molecular Medicine, Mie University Graduate School of Medicine, Tsu, 514-8507, Japan.
Oikawa S; Department of Environmental and Molecular Medicine, Mie University Graduate School of Medicine, Tsu, 514-8507, Japan.
Kobayashi H; Department of Environmental and Molecular Medicine, Mie University Graduate School of Medicine, Tsu, 514-8507, Japan.
Nakamura S; Department of Otorhinolaryngology-Head and Neck Surgery, Mie University Graduate School of Medicine, Tsu, 514-8507, Japan.
Ishinaga H; Department of Otorhinolaryngology-Head and Neck Surgery, Mie University Graduate School of Medicine, Tsu, 514-8507, Japan.
Zhang Z; Department of Otorhinolaryngology-Head and Neck Surgery, First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, China.
Huang G; Key Laboratory of High-Incidence-Tumor Prevention & Treatment, Guangxi Medical University, Nanning, 530021, China.
Takeuchi K; Department of Otorhinolaryngology-Head and Neck Surgery, Mie University Graduate School of Medicine, Tsu, 514-8507, Japan. .
Murata M; Department of Environmental and Molecular Medicine, Mie University Graduate School of Medicine, Tsu, 514-8507, Japan. .; Pokaż więcej
Źródło:: BMC cancer [BMC Cancer] 2021 Aug 18; Vol. 21 (1), pp. 929. Date of Electronic Publication: 2021 Aug 18.
Typ publikacji:: Journal Article
MeSH Terms:: Macrophage Activation*
Coinfection/*complications
Epstein-Barr Virus Infections/*complications
Intramolecular Oxidoreductases/*metabolism
Macrophage Migration-Inhibitory Factors/*metabolism
Nasopharyngeal Carcinoma/*pathology
Nasopharyngeal Neoplasms/*pathology
Papillomavirus Infections/*complications
Alphapapillomavirus/isolation & purification ; Case-Control Studies ; Epstein-Barr Virus Infections/virology ; Female ; Follow-Up Studies ; Herpesvirus 4, Human/isolation & purification ; Humans ; Japan/epidemiology ; Male ; Middle Aged ; Nasopharyngeal Carcinoma/epidemiology ; Nasopharyngeal Carcinoma/metabolism ; Nasopharyngeal Carcinoma/virology ; Nasopharyngeal Neoplasms/epidemiology ; Nasopharyngeal Neoplasms/metabolism ; Nasopharyngeal Neoplasms/virology ; Papillomavirus Infections/virology ; Prognosis ; RNA, Viral/metabolism

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 19.

Tytuł:: Prognostic value of EBV DNA and platelet-to-lymphocyte ratio in patients with non-metastatic nasopharyngeal carcinoma: a retrospective study.
Autorzy:: Dong H; Department of Radiation Oncology, The First Affiliated Hospital of Guangxi Medical University, No. 6, Shuangyong Road, Nanning, Guangxi, 530021, People's Republic of China.; Department of Radiotherapy and Chemotherapy, The Second People's Hospital of Yichang, No. 21, Xiling 1st Road, Yichang, Hubei, 443000, People's Republic of China.
Huang Z; Department of Radiation Oncology, The First Affiliated Hospital of Guangxi Medical University, No. 6, Shuangyong Road, Nanning, Guangxi, 530021, People's Republic of China.; Department of Oncology, Langdong Hospital of Guangxi Medical University, No. 60, Jinhu North Road, Nanning, Guangxi, 530028, People's Republic of China.
Yang D; Department of Radiation Oncology, The First Affiliated Hospital of Guangxi Medical University, No. 6, Shuangyong Road, Nanning, Guangxi, 530021, People's Republic of China.
Li Z; Department of Radiation Oncology, The First Affiliated Hospital of Guangxi Medical University, No. 6, Shuangyong Road, Nanning, Guangxi, 530021, People's Republic of China.
Huang H; Department of Radiation Oncology, The First Affiliated Hospital of Guangxi Medical University, No. 6, Shuangyong Road, Nanning, Guangxi, 530021, People's Republic of China.
Meng Z; Department of Radiation Oncology, The First Affiliated Hospital of Guangxi Medical University, No. 6, Shuangyong Road, Nanning, Guangxi, 530021, People's Republic of China.
Qin Y; Department of Radiation Oncology, The First Affiliated Hospital of Guangxi Medical University, No. 6, Shuangyong Road, Nanning, Guangxi, 530021, People's Republic of China. .
Kang M; Department of Radiation Oncology, The First Affiliated Hospital of Guangxi Medical University, No. 6, Shuangyong Road, Nanning, Guangxi, 530021, People's Republic of China. .; Pokaż więcej
Źródło:: BMC cancer [BMC Cancer] 2023 Jul 18; Vol. 23 (1), pp. 673. Date of Electronic Publication: 2023 Jul 18.
Typ publikacji:: Journal Article
MeSH Terms:: Epstein-Barr Virus Infections*
Nasopharyngeal Neoplasms*/pathology
Humans ; Prognosis ; Nasopharyngeal Carcinoma/pathology ; Herpesvirus 4, Human/genetics ; Retrospective Studies ; Neoplasm Staging ; DNA, Viral ; Lymphocytes/pathology

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 20.

Tytuł:: Valero's host index is useful in predicting radiation-induced trismus and osteoradionecrosis of the jaw risks in locally advanced nasopharyngeal carcinoma patients.
Autorzy:: Topkan E; Department of Radiation Oncology, Medical Faculty, Baskent University, Adana, Turkey. .
Somay E; Department of Oral and Maxillofacial Surgery, Faculty of Dentistry, Baskent University, Ankara, Turkey.
Yilmaz B; Department of Oral and Maxillofacial Radiology, School of Dental Medicine, Bahcesehir University, Istanbul, Turkey.
Pehlivan B; Department of Radiation Oncology, Bahcesehir University, Istanbul, Turkey.
Selek U; Department of Radiation Oncology, School of Medicine, Koc University, Istanbul, Turkey.; Pokaż więcej
Źródło:: BMC cancer [BMC Cancer] 2023 Jul 12; Vol. 23 (1), pp. 651. Date of Electronic Publication: 2023 Jul 12.
Typ publikacji:: Journal Article
MeSH Terms:: Osteoradionecrosis*/diagnosis
Osteoradionecrosis*/etiology
Carcinoma*
Nasopharyngeal Neoplasms*/radiotherapy
Humans ; Nasopharyngeal Carcinoma/radiotherapy ; Trismus/etiology

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Informacja

Wyszukujesz frazę ""Nasopharyngeal carcinoma"" wg kryterium: Temat

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Wydawca

Język